Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

VTRS

Viatris Inc

Pharmaceutical Preparations · SIC 2834CIK 1792044Held by 8 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$14.25B
Net Income FY2025
$(3.52B)
EPS (Basic, as reported)
$-3.00
Net Margin FY2025
-24.7%
ROE FY2025
-23.9%
Total Equity
$14.71B
Shares Out
1.15B
Business description

Viatris Inc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 11,269 → 14,250 +3.4% CAGR
Revenue11,26911,37011,82017,81416,21815,38814,69314,250
Cost of revenue(7,432)(7,603)(8,149)(12,311)(9,766)(8,988)(9,116)(9,286)
Gross profit4,0023,8983,7975,5766,4976,4395,6245,014
Research & development(704)(640)(555)(751)————
Selling, general & administrative(2,441)(2,564)(3,345)(4,529)(4,179)(4,650)(4,426)(3,794)
Total operating expenses(3,096)(3,182)(4,007)(5,609)(4,882)(5,672)(5,613)(7,677)
Operating income906716(211)(34)1,61576610(2,663)
Interest expense(542)(517)(498)(636)(592)(573)(550)(471)
Other income (expense), net(65)(44)(13)61,79110(83)(531)
Pre-tax income298154(721)(664)2,813203(623)(3,665)
Income tax expense(54)(138)(51)(605)(735)(148)(11)(150)
Net income35317(670)(1,269)2,07955(634)(3,515)
EPS — basic$0.69$0.03($1.11)($1.05)$1.71$0.05($0.53)($3.00)
EPS — diluted$0.68$0.03($1.11)($1.05)$1.71$0.05($0.53)($3.00)
Shares outstanding — basic (M)5155166011,2091,2121,200——
Shares outstanding — diluted (M)5175176011,2091,2171,207——
  • ⚑ Weighted-average shares changed ×2.01 between FY2020 and FY2021 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.